• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

HBV 免疫逃逸的机制。

Mechanisms of HBV immune evasion.

机构信息

Department of Immunology, University of Toronto, Toronto, ON, Canada; Toronto Centre for Liver Disease, Toronto General Hospital Research Institute, University Health Network, Toronto, ON, Canada.

Department of Immunology, University of Toronto, Toronto, ON, Canada; Toronto Centre for Liver Disease, Toronto General Hospital Research Institute, University Health Network, Toronto, ON, Canada.

出版信息

Antiviral Res. 2020 Jul;179:104816. doi: 10.1016/j.antiviral.2020.104816. Epub 2020 May 7.

DOI:10.1016/j.antiviral.2020.104816
PMID:32387476
Abstract

The concept of immune evasion is a longstanding topic of debate during chronic Hepatitis B Virus infection. The 292 million individuals chronically infected by HBV are clear evidence that the virus avoids elimination by the immune system. The exact mechanisms of immune evasion remain undefined and are distinct, but likely interconnected, between innate and adaptive immunity. There is a significant body of evidence that supports peripheral tolerance and exhaustion of adaptive immunity but our understanding of the role that central tolerance plays is still developing. Innate immunity instructs the adaptive immune response and subversion of its functionality will impact both T and B cell responses. However, literature around the interaction of HBV with innate immunity is inconsistent, with reports suggesting that HBV avoids innate recognition, suppresses innate recognition, or activates innate immunity. This complexity has led to confusion and controversy. This review will discuss the mechanisms of central and peripheral tolerance/exhaustion of adaptive immunity in the context of chronic HBV infection. We also cover the interaction of HBV with cells of the innate immune system and propose concepts for the heterogeneity of responses in chronically infected patients.

摘要

免疫逃逸是慢性乙型肝炎病毒感染过程中一个长期存在的争论话题。2.92 亿慢性乙型肝炎病毒感染者清楚地表明,病毒逃避了免疫系统的清除。免疫逃逸的确切机制尚不清楚,先天免疫和适应性免疫之间存在明显但可能相互关联的区别。有大量证据支持外周耐受和适应性免疫衰竭,但我们对中枢耐受所起作用的理解仍在不断发展。先天免疫指导适应性免疫反应,其功能的颠覆将影响 T 细胞和 B 细胞反应。然而,关于乙型肝炎病毒与先天免疫相互作用的文献并不一致,有报道称乙型肝炎病毒逃避先天识别、抑制先天识别或激活先天免疫。这种复杂性导致了困惑和争议。本综述将讨论慢性乙型肝炎病毒感染中适应性免疫的中枢和外周耐受/衰竭的机制。我们还涵盖了乙型肝炎病毒与先天免疫细胞的相互作用,并为慢性感染患者的异质性反应提出了概念。

相似文献

1
Mechanisms of HBV immune evasion.HBV 免疫逃逸的机制。
Antiviral Res. 2020 Jul;179:104816. doi: 10.1016/j.antiviral.2020.104816. Epub 2020 May 7.
2
Innate and adaptive immune responses in chronic hepatitis B virus infections: towards restoration of immune control of viral infection.慢性乙型肝炎病毒感染中的固有和适应性免疫反应:恢复对病毒感染的免疫控制。
Gut. 2012 Dec;61(12):1754-64. doi: 10.1136/gutjnl-2011-301073. Epub 2011 Dec 9.
3
Innate immune recognition and modulation in hepatitis D virus infection.先天免疫识别与乙型肝炎病毒感染的调节。
World J Gastroenterol. 2020 Jun 7;26(21):2781-2791. doi: 10.3748/wjg.v26.i21.2781.
4
Innate immune responses in hepatitis B virus (HBV) infection.乙型肝炎病毒(HBV)感染中的固有免疫应答。
Virol J. 2014 Feb 7;11:22. doi: 10.1186/1743-422X-11-22.
5
Reversal of hepatitis B virus-induced systemic immune tolerance by intrinsic innate immune stimulation.固有先天免疫刺激逆转乙型肝炎病毒诱导的全身免疫耐受。
J Gastroenterol Hepatol. 2013 Aug;28 Suppl 1:132-7. doi: 10.1111/jgh.12034.
6
Advances in Targeting the Innate and Adaptive Immune Systems to Cure Chronic Hepatitis B Virus Infection.靶向固有和适应性免疫系统以治愈慢性乙型肝炎病毒感染的研究进展。
Front Immunol. 2020 Feb 7;10:3127. doi: 10.3389/fimmu.2019.03127. eCollection 2019.
7
Interplay between hepatitis B virus and the innate immune responses: implications for new therapeutic strategies.乙型肝炎病毒与固有免疫反应的相互作用:对新治疗策略的启示。
Virol Sin. 2014 Feb;29(1):17-24. doi: 10.1007/s12250-014-3412-3. Epub 2014 Jan 20.
8
Innate immunity and HBV persistence.固有免疫与乙型肝炎病毒持续感染。
Curr Opin Virol. 2021 Aug;49:13-20. doi: 10.1016/j.coviro.2021.04.003. Epub 2021 May 13.
9
Regulation of microRNA by hepatitis B virus infection and their possible association with control of innate immunity.乙型肝炎病毒感染对微小RNA的调控及其与先天免疫控制的可能关联。
World J Gastroenterol. 2014 Jun 21;20(23):7197-206. doi: 10.3748/wjg.v20.i23.7197.
10
Immune response and treatment targets of chronic hepatitis B virus infection: innate and adaptive immunity.慢性乙型肝炎病毒感染的免疫反应和治疗靶点:固有和适应性免疫。
Front Cell Infect Microbiol. 2023 Jun 22;13:1206720. doi: 10.3389/fcimb.2023.1206720. eCollection 2023.

引用本文的文献

1
Detecting early kidney injury due to host-virus interaction response in treatment-naive CHB-a pilot study.在初治慢性乙型肝炎患者中检测宿主-病毒相互作用反应所致的早期肾损伤——一项试点研究
Front Cell Infect Microbiol. 2025 Jul 29;15:1601678. doi: 10.3389/fcimb.2025.1601678. eCollection 2025.
2
Single-cell RNA sequencing of bone marrow reveals the immune response mechanisms of lymphocytes under avian leukosis virus subgroup J infection.骨髓单细胞RNA测序揭示了J亚群禽白血病病毒感染下淋巴细胞的免疫反应机制。
Poult Sci. 2025 May;104(5):104995. doi: 10.1016/j.psj.2025.104995. Epub 2025 Mar 8.
3
Liver diseases: epidemiology, causes, trends and predictions.
肝脏疾病:流行病学、病因、趋势及预测
Signal Transduct Target Ther. 2025 Feb 5;10(1):33. doi: 10.1038/s41392-024-02072-z.
4
Surveillance Following Hepatitis B Surface Antigen Loss: An Issue Requiring Attention.乙肝表面抗原消失后的监测:一个需要关注的问题。
Pathogens. 2024 Dec 27;14(1):8. doi: 10.3390/pathogens14010008.
5
Viral Hepatitis: Host Immune Interaction, Pathogenesis and New Therapeutic Strategies.病毒性肝炎:宿主免疫相互作用、发病机制及新治疗策略
Pathogens. 2024 Sep 5;13(9):766. doi: 10.3390/pathogens13090766.
6
Viral Factors in Modulation of Host Immune Response: A Route to Novel Antiviral Agents and New Therapeutic Approaches.病毒因素对宿主免疫反应的调节:新型抗病毒药物和新治疗方法的途径。
Int J Mol Sci. 2024 Aug 29;25(17):9408. doi: 10.3390/ijms25179408.
7
Using exploratory pharmacokinetic and pharmacodynamic analyses to predict the probability of flu-like symptoms in healthy volunteers and patients with chronic hepatitis B treated with the toll-like receptor 7 agonist ruzotolimod.采用探索性药代动力学和药效学分析预测 Toll 样受体 7 激动剂 ruzotolimod 治疗慢性乙型肝炎健康志愿者和患者出现流感样症状的概率。
Clin Transl Sci. 2024 Aug;17(8):e13896. doi: 10.1111/cts.13896.
8
Current updates on the molecular and genetic signals as diagnostic and therapeutic targets for hepatitis B virus-associated hepatic malignancy.乙型肝炎病毒相关肝脏恶性肿瘤的分子和遗传信号作为诊断和治疗靶点的最新进展。
Heliyon. 2024 Jul 8;10(14):e34288. doi: 10.1016/j.heliyon.2024.e34288. eCollection 2024 Jul 30.
9
Conserved Functions of X Proteins to Inhibit Type-I Interferon Signaling.X 蛋白抑制 I 型干扰素信号转导的保守功能。
Int J Mol Sci. 2024 Mar 28;25(7):3753. doi: 10.3390/ijms25073753.
10
Recent advances in different interactions between toll-like receptors and hepatitis B infection: a review.近年来 Toll 样受体与乙型肝炎病毒感染相互作用的研究进展:综述。
Front Immunol. 2024 Mar 13;15:1363996. doi: 10.3389/fimmu.2024.1363996. eCollection 2024.